These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 20653750)

  • 1. The high prevalence of malnutrition in elderly diabetic patients: implications for anti-diabetic drug treatments.
    Vischer UM; Perrenoud L; Genet C; Ardigo S; Registe-Rameau Y; Herrmann FR
    Diabet Med; 2010 Aug; 27(8):918-24. PubMed ID: 20653750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of insulin therapy in patients with type 2 diabetes mellitus: beyond basal insulin.
    Blak BT; Smith HT; Hards M; Curtis BH; Ivanyi T
    Diabet Med; 2012 Jul; 29(7):e13-20. PubMed ID: 22268988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study.
    Blonde L; Merilainen M; Karwe V; Raskin P;
    Diabetes Obes Metab; 2009 Jun; 11(6):623-31. PubMed ID: 19515182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction in glycated albumin can predict change in HbA1c: comparison of oral hypoglycaemic agent and insulin treatments.
    Won HK; Kim KJ; Lee BW; Kang ES; Cha BS; Lee HC
    Diabet Med; 2012 Jan; 29(1):74-9. PubMed ID: 21781151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fasting plasma glucose 6-12 weeks after starting insulin glargine predicts likelihood of treatment success: a pooled analysis.
    Karl D; Zhou R; Vlajnic A; Riddle M
    Diabet Med; 2012 Jul; 29(7):933-6. PubMed ID: 22413808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of insulin and oral anti-diabetic agents on glucose metabolism, vascular dysfunction and skeletal muscle inflammation in type 2 diabetic subjects.
    Joya-Galeana J; Fernandez M; Cervera A; Reyna S; Ghosh S; Triplitt C; Musi N; DeFronzo RA; Cersosimo E
    Diabetes Metab Res Rev; 2011 May; 27(4):373-82. PubMed ID: 21309063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial.
    Barnett AH; Burger J; Johns D; Brodows R; Kendall DM; Roberts A; Trautmann ME
    Clin Ther; 2007 Nov; 29(11):2333-48. PubMed ID: 18158075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biphasic insulin aspart 30 treatment in patients with type 2 diabetes poorly controlled on prior diabetes treatment: results from the PRESENT study.
    Sharma SK; Al-Mustafa M; Oh SJ; Azar ST; Shestakova M; Guler S; Vaz JA
    Curr Med Res Opin; 2008 Mar; 24(3):645-52. PubMed ID: 18215338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors for successful insulin therapy in subjects with type 2 diabetes.
    Wolffenbuttel BH; Sels JP; Rondas-Colbers GJ; Menheere PP
    Neth J Med; 1999 Feb; 54(2):63-9. PubMed ID: 10079680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study.
    Yurgin N; Secnik K; Lage MJ
    Clin Ther; 2007 Feb; 29(2):316-25. PubMed ID: 17472823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of glycaemic control in patients with Type 1 diabetes commencing continuous subcutaneous insulin infusion therapy.
    Shalitin S; Gil M; Nimri R; de Vries L; Gavan MY; Phillip M
    Diabet Med; 2010 Mar; 27(3):339-47. PubMed ID: 20536498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial.
    Weng J; Li Y; Xu W; Shi L; Zhang Q; Zhu D; Hu Y; Zhou Z; Yan X; Tian H; Ran X; Luo Z; Xian J; Yan L; Li F; Zeng L; Chen Y; Yang L; Yan S; Liu J; Li M; Fu Z; Cheng H
    Lancet; 2008 May; 371(9626):1753-60. PubMed ID: 18502299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High normal HbA(1c) levels were associated with impaired insulin secretion without escalating insulin resistance in Japanese individuals: the Toranomon Hospital Health Management Center Study 8 (TOPICS 8).
    Heianza Y; Arase Y; Fujihara K; Tsuji H; Saito K; Hsieh SD; Kodama S; Shimano H; Yamada N; Hara S; Sone H
    Diabet Med; 2012 Oct; 29(10):1285-90. PubMed ID: 22486679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.
    Ushakova O; Sokolovskaya V; Morozova A; Valeeva F; Zanozina O; Sazonova O; Zhadanova E; Starceva M; Kazakova E; Saifullina M; Shapiro I; Tarasov A; Al-Tayar B; Starkova N
    Clin Ther; 2007 Nov; 29(11):2374-84. PubMed ID: 18158078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addition of biphasic insulin aspart 30 to optimized metformin and pioglitazone treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through Insulin plus Oral ageNts).
    Raskin P; Matfin G; Schwartz SL; Chaykin L; Chu PL; Braceras R; Wynne A
    Diabetes Obes Metab; 2009 Jan; 11(1):27-32. PubMed ID: 17941873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensification of diabetes medication and risk for 30-day readmission.
    Wei NJ; Wexler DJ; Nathan DM; Grant RW
    Diabet Med; 2013 Feb; 30(2):e56-62. PubMed ID: 23126686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extent and Predictors of Poor Glycaemic Control among Elderly Pakistani Patients with Type 2 Diabetes Mellitus: A Multi-Centre Cross-Sectional Study.
    Atif M; Saleem Q; Asghar S; Malik I; Ahmad N
    Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30658518
    [No Abstract]   [Full Text] [Related]  

  • 20. The ratio of leptin to adiponectin can be used as an index of insulin resistance.
    Oda N; Imamura S; Fujita T; Uchida Y; Inagaki K; Kakizawa H; Hayakawa N; Suzuki A; Takeda J; Horikawa Y; Itoh M
    Metabolism; 2008 Feb; 57(2):268-73. PubMed ID: 18191059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.